| External factors: | Lipid lowering therapy |
| Aging type: | Prevent |
| Aging characteristic: |
| Category: | Other |
| Phenotype: | Coronary artery disease |
| Experiment: | FISH |
| Description: | The aggressive LLT group showed reduced LDL cholesterol levels in CAD patients after 12 months of therapy. |
| Target gene: | MIR-23A//TRF2 |
| R-EF-Target gene: | Downregulation//Upregulation |
| Official symbol(s): | MIR-23A//TERF2 |
| Target gene experiment: | qRT-RCR//Flow cytometry |
| Target gene description: | Aggressive LLT markedly decreased levels of miR-23a (2.78±1.29 vs. 2.09 ±1.17, P < 0.01) and increased levels of TRF2 (2.98 ± 1.44 vs.3.52 ± 1.34, P < 0.01). |
| Regulatory pathway: | -- |
| R-EF-Pathway: | -- |
| Pathway experiment: | -- |
| Pathway description: | -- |
Annotation: